Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1.
暂无分享,去创建一个
E. De Clercq | P. Cherepanov | G. Reekmans | J. Ojwang | E. Clercq | Z. Debyser | J. Esté | R. Steinfeld | G. David | R. Rando | Robert Steinfeld | Guido David | Robert F. Rando | Peter Cherepanov | Gunther Reekmans
[1] Y. Pommier,et al. Ion selective folding of loop domains in a potent anti-HIV oligonucleotide. , 1997, Biochemistry.
[2] Y. Pommier,et al. Inhibition of the human immunodeficiency virus type 1 integrase by guanosine quartet structures. , 1996, Biochemistry.
[3] Q. Jia,et al. Inhibitors of HIV-1 replication that inhibit HIV integrase , 1996 .
[4] Y. Pommier,et al. Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase. , 1996, Molecular pharmacology.
[5] M. Hogan,et al. Intramolecular G-quartet Motifs Confer Nuclease Resistance to a Potent Anti-HIV Oligonucleotide (*) , 1996, The Journal of Biological Chemistry.
[6] H. Buc,et al. The Metal Ion-induced Cooperative Binding of HIV-1 Integrase to DNA Exhibits a Marked Preference for Mn(II) Rather than Mg(II) (*) , 1996, The Journal of Biological Chemistry.
[7] Y. Pommier,et al. (-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase. , 1996, Journal of medicinal chemistry.
[8] R A Houghten,et al. Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[9] Y. Pommier,et al. T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1 , 1995, Antimicrobial agents and chemotherapy.
[10] Rolf Boelens,et al. The DNA-binding domain of HIV-1 integrase has an SH3-like fold , 1995, Nature Structural Biology.
[11] Lee Sp,et al. Substrate-length-dependent activities of human immunodeficiency virus type 1 integrase in vitro: differential DNA binding affinities associated with different lengths of substrates. , 1995 .
[12] Lee Sp,et al. CHARACTERIZATION OF MG2+-DEPENDENT 3'-PROCESSING ACTIVITY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INTEGRASE IN VITRO : REAL-TIME KINETIC STUDIES USING FLUORESCENCE RESONANCE ENERGY TRANSFER , 1995 .
[13] A M Gronenborn,et al. Solution structure of the DNA binding domain of HIV-1 integrase. , 1995, Biochemistry.
[14] Erik De Clercq,et al. Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections. , 1995 .
[15] P. Brown,et al. An Essential Interaction between Distinct Domains of HIV-1 Integrase Mediates Assembly of the Active Multimer (*) , 1995, The Journal of Biological Chemistry.
[16] M. McGrath,et al. Suppression of Human Immunodeficiency Virus Type 1 Activity in Vitro by Oligonucleotides Which Form Intramolecular Tetrads (*) , 1995, The Journal of Biological Chemistry.
[17] A. Engelman,et al. Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. , 1994, Science.
[18] D. Ecker,et al. Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320). , 1994, AIDS research and human retroviruses.
[19] J. Mouscadet,et al. Triplex-mediated inhibition of HIV DNA integration in vitro. , 1994, The Journal of biological chemistry.
[20] K. Kohn,et al. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. , 1994, Biochemical pharmacology.
[21] P. Brown,et al. A stable complex between integrase and viral DNA ends mediates human immunodeficiency virus integration in vitro. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[22] Y. Pommier,et al. Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. Plasterk,et al. A high-throughput, non-radioactive microtiter plate assay for activity of the human immunodeficiency virus integrase protein. , 1994, Nucleic acids research.
[24] D. Hazuda,et al. A novel assay for the DNA strand-transfer reaction of HIV-1 integrase. , 1994, Nucleic acids research.
[25] R. Plasterk,et al. Activities of the feline immunodeficiency virus integrase protein produced in Escherichia coli , 1994, Journal of virology.
[26] D. Ecker,et al. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[27] A. Skalka,et al. Rapid solution assays for retroviral integration reactions and their use in kinetic analyses of wild-type and mutant Rous sarcoma virus integrases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[28] F. Bushman,et al. Identification of discrete functional domains of HIV‐1 integrase and their organization within an active multimeric complex. , 1993, The EMBO journal.
[29] R. Plasterk,et al. Complementation between HIV integrase proteins mutated in different domains. , 1993, The EMBO journal.
[30] K. Kohn,et al. Inhibitors of human immunodeficiency virus integrase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[31] S. Ueda,et al. Integration is essential for efficient gene expression of human immunodeficiency virus type 1 , 1993, Journal of virology.
[32] W. Schleif,et al. Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells , 1992, Journal of virology.
[33] P. Brown,et al. Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. , 1992, Science.
[34] F. Bushman,et al. Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[35] P. Brown,et al. Correct integration of retroviral DNA in vitro , 1987, Cell.
[36] Broder,et al. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[37] E. De Clercq,et al. Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections. , 1995, Journal of medicinal chemistry.
[38] A. Skalka,et al. The retroviral enzymes. , 1994, Annual review of biochemistry.